Literature DB >> 11862096

Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine.

Sandhya Narasimhan1, Hajib N Madhavan, Lily Therese K.   

Abstract

PURPOSE: To develop a reliable in vitro drug susceptibility test against Acanthamoeba isolates and to determine the minimum cysticidal concentration (MCC) of the drug.
METHODS: Doubling dilutions of polyhexamethylene biguanide (PHMB) from 3,200 microg/mL to 3.125 microg/mL and chlorhexidine from 3,200 microg/mL to 1.5625 microg/mL were made in Durham tubes and tested against cysts of 19 Acanthamoeba isolates from keratitis. After the exposure to the drugs for 48 hours, the cysts were washed free of drugs by centrifugation. The deposit (cysts) was cultured on nonnutrient agar plates seeded with heat-killed Escherichia coli. The growth of trophozoites from cysts exposed to each of the dilution was recorded by microscopy to estimate the MCC of the drug.
RESULTS: The minimum cysticidal concentration of PHMB varied from 25 microg/mL to 100 microg/mL and that of chlorhexidine varied from 1.56 microg/mL to 100 microg/mL. The mean MCC value for PHMB was 55.26 microg/mL and that for chlorhexidine 32.81 microg/mL. Minimum cysticidal concentration 50 (MCC50) of PHMB and chlorhexidine on Acanthamoeba isolates was 50.0 microg/mL and 25.0 microg/mL, respectively. Anti-Acanthamoeba activity of chlorhexidine was higher than that of PHMB and this was statistically significant (p = 0.036). The end point of the results of this method was the detection of the viable cysts undergoing excystment and multiplication of trophozoites with a reproducible and clear-cut estimation of the MCC of PHMB and chlorhexidine.
CONCLUSION: The in vitro method described can be used as a standard test for assay of MCC of drugs on Acanthamoeba isolates and to study the susceptibility pattern of newer water-soluble anti-Acanthamoeba drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11862096     DOI: 10.1097/00003226-200203000-00016

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  19 in total

1.  Effect of combined chlorhexidine gluconate and neosporin on experimental keratitis with two pathogenic strains of Acanthamoeba.

Authors:  Zubeyde Akin Polat; Ayse Vural
Journal:  Parasitol Res       Date:  2011-12-09       Impact factor: 2.289

2.  Evaluation of the activity of new cationic carbosilane dendrimers on trophozoites and cysts of Acanthamoeba polyphaga.

Authors:  Irene Heredero-Bermejo; Jose Luis Copa-Patiño; Juan Soliveri; Elena Fuentes-Paniagua; Francisco Javier de la Mata; Rafael Gomez; Jorge Perez-Serrano
Journal:  Parasitol Res       Date:  2014-10-31       Impact factor: 2.289

3.  Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts.

Authors:  Ricardo Lamy; Elliot Chan; Samuel D Good; Vicky Cevallos; Travis C Porco; Jay M Stewart
Journal:  Clin Exp Ophthalmol       Date:  2016-02-23       Impact factor: 4.207

4.  Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.

Authors:  Regis P Kowalski; Salwa Abdel Aziz; Eric G Romanowski; Robert M Q Shanks; Amy C Nau; Leela V Raju
Journal:  JAMA Ophthalmol       Date:  2013-11       Impact factor: 7.389

Review 5.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

6.  Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs.

Authors:  Brian Shing; Mina Balen; James H McKerrow; Anjan Debnath
Journal:  Expert Rev Anti Infect Ther       Date:  2021-05-19       Impact factor: 5.091

7.  Polyhexamethylene biguanide functionalized cationic silver nanoparticles for enhanced antimicrobial activity.

Authors:  Sumaira Ashraf; Nasrin Akhtar; Muhammad Afzal Ghauri; Muhammad Ibrahim Rajoka; Zafar M Khalid; Irshad Hussain
Journal:  Nanoscale Res Lett       Date:  2012-05-24       Impact factor: 4.703

8.  The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellanii.

Authors:  Brian Shing; Seema Singh; Larissa M Podust; James H McKerrow; Anjan Debnath
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

Review 9.  Cationic antimicrobial polymers and their assemblies.

Authors:  Ana Maria Carmona-Ribeiro; Letícia Dias de Melo Carrasco
Journal:  Int J Mol Sci       Date:  2013-05-10       Impact factor: 5.923

10.  Diversity of microbial species implicated in keratitis: a review.

Authors:  Elisabeth Karsten; Stephanie Lousie Watson; Leslie John Ray Foster
Journal:  Open Ophthalmol J       Date:  2012-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.